David Johnson

David Johnson

Chief Operating Officer at VERA THERAPEUTICS, INC.

Net worth: 195 608 $ as of 2026-10-30

56 year
Health Technology
Consumer Services

Profile

David L.
Johnson
is currently an Independent Director at Caribou Biosciences, Inc. since 2022 and Chief Operating Officer at Vera Therapeutics, Inc. since 2024.
Formerly, Mr. Johnson was Vice President-Sales & Marketing at Gilead Sciences, Inc. from 2003 to 2018 and Chief Commercial Officer at Global Blood Therapeutics, Inc. from 2018 to 2022.
Education includes an undergraduate degree from the University of Puget Sound and an MBA from Kenan-Flagler Business School.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-03-23 6,314 ( 0.01% ) 195 608 $ 2026-10-30
2026-04-19 0 ( -.--% ) - $ 2026-10-30

David Johnson active positions

CompaniesPositionStart
VERA THERAPEUTICS, INC. Chief Operating Officer 2024-06-30
CARIBOU BIOSCIENCES, INC. Director/Board Member 2022-05-10

Former positions of David Johnson

CompaniesPositionEnd
GLOBAL BLOOD THERAPEUTICS, INC. Corporate Officer/Principal 2022-11-30
GILEAD SCIENCES, INC. Sales & Marketing 2017-12-31
See the detail of David Johnson's experience

Education of David Johnson

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

90

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies6

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology